Jiangxi trunche group, located in the high technology development area of nanchang city, jiangxi province, with an area of more than 100 acres, owns two major drug and health-care production bases: jiangxikawa qui pharmaceutical industries ltd. And south changkawache health products ltd., with more than 8,000 square metres in gmp standard production workshops and more than 20 modern production lines; and has a strong technological development, advanced equipment and management science, which has been certified as pharmaceutical and health products in 2004。

Jiangxi tsichuan pharmacy, inc., is a high-technology enterprise in jiangxi province, which produces a variety of products, including chinese and western medicine, tablets, capsules, granules, oral fluids, syrup and bulk agents. The main products are: closed capsules, cold capsules, strong tremors, cold coughing particles, liver plum particles, plate blue root granules, warm gastric splatters, gastrophagus, capricorns** bubble tablets, ecstasy, chords of apricotres, pellets of pelvis and calcium glucose。

Of these, the uniquely produced closed-convulsive capsules are included in the treatment class and are recognized by the jiangxi department of science and technology as high-tech products in jiangxi province; the co-produced apricot and thermal spectrometers are certified. Zui is close and autonomously developed an organic selenium known as "the 21st amino acid in the human body": l-silent-miocyte semi-screene. The chinese name of the product, kawaschi oshivecon, is a new type of food nutrient fortifying agent with great market prospects。